Biodexa Pharmaceuticals Plc MTPH.L Stock
Biodexa Pharmaceuticals Plc Price Chart
Biodexa Pharmaceuticals Plc MTPH.L Financial and Trading Overview
Biodexa Pharmaceuticals Plc stock price | 18 GBP |
Previous Close | 0.95 GBP |
Open | 0 GBP |
Bid | 17 GBP x 0 |
Ask | 0 GBP x 0 |
Day's Range | 0 - 0 GBP |
52 Week Range | 0 - 317.8 GBP |
Volume | 1.38M GBP |
Avg. Volume | 38.93K GBP |
Market Cap | 31.2M GBP |
Beta (5Y Monthly) | 1.218955 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MTPH.L Valuation Measures
Enterprise Value | -4922052 GBP |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 48.37591 |
Price/Book (mrq) | 11.834319 |
Enterprise Value/Revenue | -7.631 |
Enterprise Value/EBITDA | 0.67 |
Trading Information
Biodexa Pharmaceuticals Plc Stock Price History
Beta (5Y Monthly) | 1.218955 |
52-Week Change | -98.055% |
S&P500 52-Week Change | 1.77% |
52 Week High | 317.8 GBP |
52 Week Low | 0 GBP |
50-Day Moving Average | 24.65 GBP |
200-Day Moving Average | 113.83 GBP |
MTPH.L Share Statistics
Avg. Volume (3 month) | 38.93K GBP |
Avg. Daily Volume (10-Days) | 62.54K GBP |
Shares Outstanding | 173.35M |
Float | 2.45M |
Short Ratio | N/A |
% Held by Insiders | 19.26% |
% Held by Institutions | 9.66% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | June 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -1169.30% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -52.50% |
Return on Equity (ttm) | -95.47% |
Income Statement
Revenue (ttm) | 645K GBP |
Revenue Per Share (ttm) | 0.13 GBP |
Quarterly Revenue Growth (yoy) | 16.69% |
Gross Profit (ttm) | 578K GBP |
EBITDA | -7350000 GBP |
Net Income Avi to Common (ttm) | -5367000 GBP |
Diluted EPS (ttm) | -0.82 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 6.42M GBP |
Total Cash Per Share (mrq) | 1.3 GBP |
Total Debt (mrq) | 713K GBP |
Total Debt/Equity (mrq) | 9.52 GBP |
Current Ratio (mrq) | 5.282 |
Book Value Per Share (mrq) | 1.521 |
Cash Flow Statement
Operating Cash Flow (ttm) | -6439000 GBP |
Levered Free Cash Flow (ttm) | -6024500 GBP |
Profile of Biodexa Pharmaceuticals Plc
Country | United Kingdom |
State | N/A |
City | Cardiff |
Address | 1 Caspian Point |
ZIP | CF10 4DQ |
Phone | 44 29 2048 0180 |
Website | https://www.midatechpharma.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 20 |
Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Q&A For Biodexa Pharmaceuticals Plc Stock
What is a current MTPH.L stock price?
Biodexa Pharmaceuticals Plc MTPH.L stock price today per share is 18 GBP.
How to purchase Biodexa Pharmaceuticals Plc stock?
You can buy MTPH.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biodexa Pharmaceuticals Plc?
The stock symbol or ticker of Biodexa Pharmaceuticals Plc is MTPH.L.
Which industry does the Biodexa Pharmaceuticals Plc company belong to?
The Biodexa Pharmaceuticals Plc industry is Biotechnology.
How many shares does Biodexa Pharmaceuticals Plc have in circulation?
The max supply of Biodexa Pharmaceuticals Plc shares is 1.73M.
What is Biodexa Pharmaceuticals Plc Price to Earnings Ratio (PE Ratio)?
Biodexa Pharmaceuticals Plc PE Ratio is 0.00000000 now.
What was Biodexa Pharmaceuticals Plc earnings per share over the trailing 12 months (TTM)?
Biodexa Pharmaceuticals Plc EPS is 0 GBP over the trailing 12 months.
Which sector does the Biodexa Pharmaceuticals Plc company belong to?
The Biodexa Pharmaceuticals Plc sector is Healthcare.
Biodexa Pharmaceuticals Plc MTPH.L included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
FTSE AIM All-Share Index FTAI | 755.91 GBP 966.76 USD |
-0.38
|
— — | 755.91 GBP 966.76 USD | 763.17 GBP 976.05 USD | — - | — — |
- {{ link.label }} {{link}}